课题基金 / 基金详情

Characterizing the human T-cell receptor repertoire by massively parallel sequencing

Characterizing the human T-cell receptor repertoire by massively parallel sequencing
通过大规模并行测序表征人类 T 细胞受体库
批准号：
190756
负责人：
Holt Rob
金额：
$65.8万
依托单位：
BC Cancer, part of PHSA (Vancouver)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2009
资助国家：
加拿大
项目状态：
已结题
起止时间：
2009-09-01 至 2013-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=190756&lang=en
关键词：
Immunoprofiling Next Generation Sequencing T Cell Receptor T Cell Repertoire

项目摘要

项目成果

Holt Rob的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
T-cells circulating in blood are the key players in your adaptive immune system and are particularly important in recognizing and killing other cells that are infected with viruses, or that carry cancer causing mutations. Because there are a vast number
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lentiviral infusion as a universal approach for genetically modified immune effector cell therapies.
  • 批准号：
    435855
  • 项目类别：
    Operating Grants
  • 资助金额：
    $46.81万
  • 财政年份：
    2020
  • 负责人：
    Holt Rob
  • 依托单位：
    BC Cancer, part of PHSA (Vancouver)
Engineering T cells to overcome an immunosuppressive solid tumour microenvironment
  • 批准号：
    369095
  • 项目类别：
    Operating Grants
  • 资助金额：
    $10.93万
  • 财政年份：
    2017
  • 负责人：
    Holt Rob
  • 依托单位：
    BC Cancer, part of PHSA (Vancouver)
Immunogenicity and HLA restriction of kinase mutations in colorectal adenoma and carcinoma patients
Linking Infectious Agents to Cancer: A Metagenomics Approach
海外基金